How do you preserve muscle on a GLP-1 (semaglutide or tirzepatide)?
Muscle preservation on a GLP-1 is engineered, not incidental. The three levers are protein intake (typically ≥1.6 g/kg/day), resistance training (2–4 sessions/week), and avoiding excessive caloric deficit. Provider-reviewed GLP-1 pathways include this architecture rather than the molecule alone.
Full answer
GLP-1 receptor agonists (semaglutide, tirzepatide) drive caloric deficit via appetite and satiety mechanisms. Any sustained caloric deficit produces some lean mass loss — the engineering question is how much. The three durable levers are protein intake (commonly ≥1.6 g/kg/day, often higher for older adults or higher trained baselines), resistance training (2–4 sessions per week with progressive load), and avoiding excessive deficit (extreme appetite suppression without compensating intake accelerates lean loss). Biomarker context matters: baseline body composition, A1c, lipids, and (where indicated) DEXA inform the pace of titration. Provider-reviewed GLP-1 pathways at oMeds include this architecture as part of the pathway rather than treating the molecule as the entire intervention.
Educational. Not a substitute for individualized provider review.
- Semaglutide pathway — Primary source · oMeds
- Reviewed by Dr. Laura Purdy, MD, MBA · Clinical Director, oMeds · Last reviewed 2026-05-29